Data / Research funding / Human Fetal Tissue
Human Fetal Tissue: 115 NIH awards ($191.1M) to 51 organizations
115 NIH awards ($191.1M) in the NIH spending category Human Fetal Tissue, to 51 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
115 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| A Multidisciplinary Center for Developing Human and Non-human Primate Brain Cell Atlases | NIH | National Institute of Mental Health | 2022 to 2025 | $20,505,732 | September 16, 2022 | June 30, 2027 | KRIEGSTEIN, ARNOLD | reporter.nih.gov |
| THE NIH NEUROBIOBANK AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,702,242 | May 1, 2025 | October 31, 2025 | BLANCHARD, THOMAS | reporter.nih.gov |
| NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020 | NIH | National Institute on Drug Abuse | 2022 to 2025 | $5,280,759 | May 1, 2025 | October 31, 2025 | KRALL, BONITA | reporter.nih.gov |
| Laboratory of Developmental Biology | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $4,519,832 | May 1, 1979 | April 30, 2028 | GLASS, IAN AMOS | reporter.nih.gov |
| Pathological Mechanisms of Human Cerebellar Malformations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,519,501 | September 1, 2016 | June 30, 2028 | MILLEN, KATHLEEN JOYCE | reporter.nih.gov |
| A single antiviral to treat multiple opportunistic infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,962,651 | June 15, 2014 | March 31, 2026 | REMISZEWSKI, STACY | reporter.nih.gov |
| Induction of autophagy to enhance CAR-T cells in HIV cure approaches | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,855,196 | June 25, 2022 | May 31, 2027 | ZHEN, ANJIE | reporter.nih.gov |
| Individualized HIV Curative Combination Strategy against Persistent HIV on ART | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,568,644 | July 7, 2025 | May 31, 2030 | MONTANER, LUIS J | reporter.nih.gov |
| Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,262 | September 20, 2013 | June 30, 2028 | PYLE, APRIL D | reporter.nih.gov |
| ENCODE Mapping Center-A Comprehensive Catalog of DNase I Hypersensitive Sites | NIH | National Human Genome Research Institute | 2021 | $3,086,945 | February 1, 2021 | January 31, 2023 | STAMATOYANNOPOULOS, JOHN A | reporter.nih.gov |
| Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy | NIH | National Cancer Institute | 2021 to 2023 | $3,015,518 | September 21, 2017 | August 31, 2024 | WEISSMAN, IRVING L. | reporter.nih.gov |
| Targeting hepatitis B virus cccDNA during HBV/HIV co-infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,993,820 | August 20, 2024 | July 31, 2029 | PLOSS, ALEXANDER | reporter.nih.gov |
| Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome | NIH | National Institute on Aging | 2021 to 2024 | $2,943,744 | April 15, 2020 | March 31, 2026 | FINKBEINER, STEVEN M | reporter.nih.gov |
| JAK-STAT Control of Zika Virus-Induced Fetal Injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,840,817 | July 1, 2019 | June 30, 2025 | ADAMS WALDORF, KRISTINA M. | reporter.nih.gov |
| Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,755,586 | August 11, 2023 | June 30, 2028 | WANG, JOANNE | reporter.nih.gov |
| Hematopoietic and Immune Development in the Human Chorion | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,664,107 | April 11, 2022 | March 31, 2027 | MUENCH, MARCUS O | reporter.nih.gov |
| Comparative Genomics of Precursor Diversity and Function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,631,720 | April 1, 2021 | February 28, 2026 | HAYDAR, TARIK F | reporter.nih.gov |
| A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,630,611 | April 15, 2022 | March 31, 2027 | MILLEN, KATHLEEN JOYCE | reporter.nih.gov |
| Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,627,918 | March 20, 2023 | February 29, 2028 | VALENTE, SUSANA T | reporter.nih.gov |
| Antigen-specific ‘kick and kill’ of the latent HIV reservoir using dendritic cells | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,530,416 | November 5, 2021 | October 31, 2026 | MAILLIARD, ROBBIE B | reporter.nih.gov |
| Characterizing Emerging Humanized Immune Mouse Models for the study of transplant rejection and infectious disease pathology (Epstein Barr Virus) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,464,113 | February 2, 2021 | August 30, 2024 | BROWN, MATTHEW E | reporter.nih.gov |
| Role and Mitigation of Inflammasomes and Inflammation During COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,428,594 | July 15, 2022 | June 30, 2027 | TING, JENNY P | reporter.nih.gov |
| Innate Immune Regulation of Zika Virus Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,388,284 | March 1, 2019 | February 28, 2025 | GALE, MICHAEL | reporter.nih.gov |
| Multipotent ABCB5-positive cell therapeutics for corneal disease | NIH | National Eye Institute | 2021 to 2022 | $2,352,662 | April 1, 2018 | January 31, 2024 | FRANK, NATASHA Y | reporter.nih.gov |
| Virologic Correlates of Heterosexual Transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,344,158 | March 15, 2002 | March 31, 2024 | HUNTER, ERIC | reporter.nih.gov |
| Thymic selection abnormalities in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,291,187 | June 26, 2023 | May 31, 2028 | SYKES, MEGAN | reporter.nih.gov |
| A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,190,887 | January 20, 2023 | December 31, 2027 | MOR, ADAM | reporter.nih.gov |
| Genetic underpinnings of craniofacial disorders explored with spatial sequencing | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,169,288 | August 1, 2023 | May 31, 2028 | RUOHOLA-BAKER, HANNELE | reporter.nih.gov |
| X chromosome regulation and role in aneuploidy | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $2,120,346 | May 1, 2019 | April 30, 2025 | DISTECHE, CHRISTINE M. | reporter.nih.gov |
| Innate immune signaling in placental antiviral defenses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,078,112 | July 17, 2019 | June 30, 2025 | COYNE, CAROLYN B | reporter.nih.gov |
| Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,942,059 | February 1, 2023 | January 31, 2028 | ZACK, JEROME A. | reporter.nih.gov |
| Regulation of human tendon development and regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,844,584 | April 15, 2023 | May 31, 2028 | HUANG, ALICE H | reporter.nih.gov |
| Impact of the gastrointestinal microbiome on HIV reservoirs | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,684,011 | September 21, 2021 | July 31, 2023 | WAHL, ANGELA RAQUEL | reporter.nih.gov |
| Developmental Timing During Cortical Development | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,657,822 | May 1, 2022 | April 30, 2027 | NOWAKOWSKI, TOMASZ | reporter.nih.gov |
| Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,647,190 | July 1, 2018 | June 30, 2024 | SU, LISHAN | reporter.nih.gov |
| Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,639,365 | January 8, 2024 | December 31, 2028 | BALAZS, ALEJANDRO BENJAMIN | reporter.nih.gov |
| Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,626,756 | June 7, 2018 | May 31, 2025 | HIOE, CATARINA E | reporter.nih.gov |
| AAV Vectored Delivery of Broadly Neutralizing Antibodies with Optimal Innate Functionality Against HIV | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,578,174 | June 15, 2023 | May 31, 2025 | BALAZS, ALEJANDRO BENJAMIN | reporter.nih.gov |
| Cone subtype specification in human retinas and organoids | NIH | National Eye Institute | 2021 to 2023 | $1,566,838 | January 1, 2020 | December 31, 2024 | JOHNSTON, ROBERT JOHN | reporter.nih.gov |
| Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,566,354 | September 24, 2018 | August 31, 2024 | SU, LISHAN | reporter.nih.gov |
| Cytotoxic immunoconjugates to deplete persistent HIV reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,543,769 | December 1, 2017 | November 30, 2024 | PINCUS, SETH H. | reporter.nih.gov |
| Understanding glial fate restriction in humans | NIH | National Institute of Mental Health | 2024 to 2025 | $1,509,234 | July 5, 2024 | January 31, 2029 | RAMANATHAN, SHARAD | reporter.nih.gov |
| Distal mRNA localization and translation in neural stem cells of the developing brain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,487,323 | September 1, 2018 | July 31, 2028 | SILVER, DEBRA L. | reporter.nih.gov |
| A Cellular Resolution Census of the Developing Human Brain | NIH | National Institute of Mental Health | 2021 | $1,390,737 | September 15, 2017 | May 31, 2023 | KRIEGSTEIN, ARNOLD | reporter.nih.gov |
| Mode of action of a new Tat HIV-1 inhibitor | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,318,950 | December 1, 2011 | June 30, 2025 | VALENTE, SUSANA T | reporter.nih.gov |
| The impact of genetic and environmental factors on meiotic prophase in the human female | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,308,732 | September 22, 2022 | May 31, 2026 | HUNT, PATRICIA | reporter.nih.gov |
| Zika Virus Capsid Protein Mediated Blockage of host microRNA machinery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,302,099 | May 1, 2019 | February 28, 2025 | ZHAO, ZHEN | reporter.nih.gov |
| GM3 Nanoparticles for Sustained Delivery of Anti-Retrovirals to Lymphatic Tissues | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,250,596 | November 8, 2017 | October 31, 2023 | GUMMULURU, SURYARAM | reporter.nih.gov |
| Glycan regulation of fetomaternal tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,245,586 | July 1, 2024 | May 31, 2029 | ERLEBACHER, ADRIAN | reporter.nih.gov |
| Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,241,707 | June 11, 2018 | May 31, 2024 | AN, DONG SUNG | reporter.nih.gov |
| HIV, HCV, Hippo, and Liver Disease Progression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,239,696 | November 3, 2017 | October 31, 2024 | CHUNG, RAYMOND T | reporter.nih.gov |
| A Scalable Platform for Exploring and Analyzing Whole Brain Tissue Cleared Images | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,237,789 | May 1, 2019 | March 31, 2025 | WU, GUORONG | reporter.nih.gov |
| Role of IFNe in immune modulation and HIV infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,215,170 | March 1, 2018 | February 28, 2025 | CHANG, THERESA L | reporter.nih.gov |
| A novel progenitor population in pancreatic endocrine cell development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,211,250 | April 1, 2019 | March 31, 2025 | SNEDDON, JULIE BETH | reporter.nih.gov |
| Next generation ultra-long acting antiretroviral formulations for HIV treatment and prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,188,509 | September 24, 2018 | June 15, 2023 | GARCIA-MARTINEZ, J. VICTOR | reporter.nih.gov |
| Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,166,250 | May 25, 2019 | April 30, 2025 | TISCH, ROLAND M | reporter.nih.gov |
| Poison exons in epilepsy and neurodevelopment | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,161,972 | June 1, 2024 | May 31, 2029 | CARVILL, GEMMA LOUISE | reporter.nih.gov |
| Gestational Iron Deficiency disrupts neural patterning in the embryo | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,128,846 | September 1, 2018 | June 30, 2025 | MAYER-PROSCHEL, MARGOT | reporter.nih.gov |
| Developing potent HIV-specific CAR T cells through optimizing antigen sensitivity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,117,190 | June 7, 2024 | April 30, 2029 | CLAIBORNE, DANIEL THOMAS | reporter.nih.gov |
| Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,108,916 | March 1, 2022 | February 28, 2027 | BOUTWELL, CHRISTIAN L. | reporter.nih.gov |
| Group B Streptococcus surface determinants of neonatal intestinal colonization and infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,101,876 | February 26, 2024 | December 31, 2028 | HOOVEN, THOMAS A | reporter.nih.gov |
| Refining iPSC-Based Spinal Cord Model Systems by Fabricating Developmentally Programmed Extracellular Matrix Cues | NIH | National Institute on Aging | 2024 to 2025 | $1,092,580 | September 1, 2024 | July 31, 2029 | KISKINIS, EVANGELOS | reporter.nih.gov |
| Identifying and targeting neoantigens in aggressive salivary carcinomas | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $1,063,994 | April 1, 2018 | March 31, 2024 | MORRIS, LUC GORDON TRANG | reporter.nih.gov |
| Mechanisms of Hedgehog Regulation of Intestinal Villus Morphogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,053,000 | March 1, 2019 | February 28, 2025 | WALTON, KATHERINE DEMPSEY | reporter.nih.gov |
| Prevention of macular pathophysiology associated with F3 misfolding | NIH | National Eye Institute | 2021 to 2022 | $968,905 | February 1, 2018 | August 31, 2023 | HULLEMAN, JOHN DOUGLAS | reporter.nih.gov |
| Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $960,269 | March 1, 2022 | February 28, 2027 | ALLEN, TODD M | reporter.nih.gov |
| Harnessing the Pathogenesis of CMV Against HIV | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $934,110 | July 22, 2024 | May 31, 2029 | YANG, OTTO O | reporter.nih.gov |
| Mapping human hematopoietic stem cell development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $917,280 | July 1, 2021 | April 30, 2025 | MIKKOLA, HANNA KATRI ANNIKKI | reporter.nih.gov |
| Functional characterization of craniofacial enhancers at single cell and single base pair resolution | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $910,042 | July 3, 2019 | June 30, 2024 | COTNEY, JUSTIN LEE | reporter.nih.gov |
| Somatic Mutations in Neurodevelopment and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $889,785 | July 1, 2022 | April 30, 2027 | SHAO, DIANE D | reporter.nih.gov |
| Intrinsic and Extrinsic Factors Contributing to Trisomy 21 Preleukemia | NIH | National Cancer Institute | 2024 to 2025 | $853,838 | May 3, 2024 | April 30, 2029 | WAGENBLAST, ELVIN | reporter.nih.gov |
| Mechanisms of HIV accessory protein mediated control of NK cell function | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $848,839 | August 1, 2025 | July 31, 2030 | CLAYTON, KIERA L. | reporter.nih.gov |
| The role of placental macrophages in cytomegalovirus infection at the maternal-fetal interface | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $836,401 | September 20, 2024 | August 31, 2029 | LIU, YAN | reporter.nih.gov |
| Modulation of Innate Immunity by KSHV | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $833,146 | September 11, 2018 | June 30, 2025 | DAMANIA, BLOSSOM A | reporter.nih.gov |
| Single-Cell-Resolved Mapping and Evolution-Driven Functional Interrogation of Human Midface Enhancers | NIH | National Institute of Dental & Craniofacial Research | 2025 | $804,478 | July 1, 2025 | March 31, 2030 | VISEL, AXEL | reporter.nih.gov |
| Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $797,798 | July 20, 2022 | January 31, 2023 | ZACK, JEROME A. | reporter.nih.gov |
| Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $782,684 | May 1, 2017 | April 30, 2022 | BREHM, MICHAEL ALLEN | reporter.nih.gov |
| Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $778,829 | June 2, 2025 | May 31, 2030 | GHOSN, ELIVER | reporter.nih.gov |
| Identifying the human skeletal stem cell. | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $761,230 | August 6, 2018 | July 31, 2024 | LONGAKER, MICHAEL T | reporter.nih.gov |
| Understanding Brain Development Through the Lens of Metabolism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $738,142 | June 1, 2019 | March 31, 2024 | BHADURI, APARNA | reporter.nih.gov |
| Manipulating Stem Cells to Provide Long Term Regeneration of Irradiated Salivary Glands | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $714,977 | July 1, 2018 | June 30, 2025 | LOMBAERT, ISABELLE M.A. | reporter.nih.gov |
| Mechanisms of salivary epithelium-specific expansion post-irradiation | NIH | National Institute of Dental & Craniofacial Research | 2025 | $714,711 | July 1, 2025 | March 31, 2030 | YING, ZHE | reporter.nih.gov |
| Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $713,872 | July 10, 2017 | June 30, 2023 | HO, DAVID D | reporter.nih.gov |
| Distal mRNA localization and translation in neural stem cells of the developing brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $712,787 | September 1, 2018 | June 30, 2024 | SILVER, DEBRA | reporter.nih.gov |
| Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $697,812 | December 1, 2017 | November 30, 2023 | SIM, FRASER JAMES | reporter.nih.gov |
| Nanopeptide Targeting of HIV-CNS Reservoirs without Reactivation | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $649,766 | May 1, 2017 | February 28, 2023 | SPECTOR, STEPHEN A | reporter.nih.gov |
| The role of inositol in Cryptococcus biology and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $649,739 | November 24, 2016 | October 31, 2023 | XUE, CHAOYANG | reporter.nih.gov |
| Immune-derived mediators of salivary gland development and differentiation | NIH | National Institute of Dental & Craniofacial Research | 2025 | $628,965 | May 1, 2025 | April 30, 2030 | MAY, ALISON | reporter.nih.gov |
| Generating protective immunity to Staphylococcus aureus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $574,032 | June 26, 2017 | May 31, 2024 | UNDERHILL, DAVID M. | reporter.nih.gov |
| High resolution analysis of human cerebellar neurogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $514,396 | August 1, 2021 | July 31, 2024 | HALDIPUR, PARTHIV | reporter.nih.gov |
| Targeting CD127-expressing tissue reservoir cells as a strategy for HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $503,139 | August 6, 2024 | July 31, 2027 | ROAN, NADIA R | reporter.nih.gov |
| Engineering HIV-resistant CAR T cells for a functional HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $498,645 | August 19, 2022 | July 31, 2024 | CLAIBORNE, DANIEL THOMAS | reporter.nih.gov |
| Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $496,151 | July 25, 2017 | June 30, 2023 | HO, DAVID D | reporter.nih.gov |
| In vitro approaches to study human cerebellar development | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $478,732 | July 16, 2024 | June 30, 2026 | HALDIPUR, PARTHIV | reporter.nih.gov |
| Mode of action of a new Tat HIV-1 inhibitor | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $458,821 | December 1, 2011 | April 1, 2022 | VALENTE, SUSANA T | reporter.nih.gov |
| Assessing the potential of reprogrammable microglia as a source of neurons in Alzheimer related dementias | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $457,610 | May 15, 2021 | October 31, 2022 | HEBERT, JEAN M | reporter.nih.gov |
| IL-1β as a novel therapeutic agent against hepatitis B virus | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $445,372 | January 1, 2024 | November 30, 2026 | OU, J.-H. JAMES | reporter.nih.gov |
| In vivo innate immune sensing of HIV-1 infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $445,254 | August 1, 2024 | June 30, 2027 | RONGVAUX, ANTHONY | reporter.nih.gov |
| Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $439,360 | March 1, 2017 | February 28, 2023 | SUTHAR, MEHUL SHAMAL | reporter.nih.gov |
| Ionic Liquids of tenofovir prodrugs for improved oral bioavailability and antiviral efficacy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $436,702 | August 24, 2023 | July 31, 2025 | DATE, ABHIJIT A | reporter.nih.gov |
| Generation of Parkinson-derived human glial progenitor cells for dopaminergic neuronal conversion | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $429,925 | June 1, 2024 | May 31, 2026 | PETERSON, DANIEL ALAN | reporter.nih.gov |
| Defining molecular and gene-regulatory dysregulation in Down Syndrome tissues and models | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $428,989 | March 10, 2022 | February 28, 2025 | DE LA TORRE-UBIETA, LUIS | reporter.nih.gov |
| Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degeneration | NIH | National Eye Institute | 2021 | $424,100 | May 1, 2018 | April 30, 2023 | MALEK, GOLDIS | reporter.nih.gov |
| In vivo CAR-T-cell HIV therapy using in vitro reconstituted virus-like particles | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $423,647 | July 1, 2024 | May 31, 2026 | GELBART, WILLIAM M | reporter.nih.gov |
| The maternal-fetal adiponectin differential and fetal fat deposition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $395,000 | August 22, 2012 | June 30, 2022 | SHAO, JIANHUA | reporter.nih.gov |
| Enhancing the TCR-induced Response of HLA-E-restricted Regulatory CD8 T Cells to Promote Allograft Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $390,019 | June 14, 2024 | July 1, 2025 | CHOI, JOHN YONGJOON | reporter.nih.gov |
| Spatial and Single Cell Transcriptomics Approach to Understand Neuron-Oligodendrocyte Communication in Human Synaptic Development | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $388,373 | February 15, 2023 | January 31, 2025 | NOBUTA, HIROKO | reporter.nih.gov |
| Development of Distinct Areas in the Human Cerebral Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $249,001 | February 1, 2024 | August 31, 2028 | QIAN, XUYU | reporter.nih.gov |
| Intrauterine sex steroids and human fetal T cell development | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $210,600 | July 1, 2017 | June 30, 2023 | HALKIAS, JOANNA | reporter.nih.gov |
| High Resolution Analysis of FOXP1 in the Developing Human Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $196,900 | April 15, 2024 | March 31, 2025 | ALDINGER, KIMBERLY ANNE | reporter.nih.gov |
| Integrated multi-omics analyses of early mammalian craniofacial development | NIH | National Institute of Dental & Craniofacial Research | 2021 | $164,000 | January 8, 2020 | December 31, 2022 | COTNEY, JUSTIN LEE | reporter.nih.gov |
| Atypical Formation of Fiber Pathways and Cortical Folding in the Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $145,007 | July 1, 2019 | July 31, 2021 | TAKAHASHI (OKI), EMI | reporter.nih.gov |
| Development of Distinct Areas in the Human Cerebral Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $127,305 | February 1, 2024 | January 31, 2026 | QIAN, XUYU | reporter.nih.gov |
| Macrophage identity as a function of cell of origin | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $122,839 | August 21, 2025 | July 31, 2027 | FRENIS, KATIE | reporter.nih.gov |
| Understanding the role of cytosolic NADH production in maintaining aerobic glycolysis in the retina | NIH | National Eye Institute | 2021 | $36,130 | March 1, 2020 | December 17, 2021 | BISBACH, CELIA | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 47 | $39,036,456 | 0 | $0 |
| 2024 | 49 | $34,839,934 | 0 | $0 |
| 2023 | 46 | $32,198,584 | 0 | $0 |
| 2022 | 56 | $42,172,430 | 0 | $0 |
| 2021 | 61 | $42,837,626 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 54 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 54 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 54 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.